Metrika članka

  • citati u SCindeksu: [1]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:3
  • preuzimanja u poslednjih 30 dana:3
članak: 1 od 1  
Back povratak na rezultate
Vojnosanitetski pregled
2005, vol. 62, br. 10, str. 757-761
jezik rada: engleski
vrsta rada: aktuelni problemi
doi:10.2298/VSP0510757J
Clinical pharmacology in health care service
(naslov ne postoji na srpskom)
Clinical Hospital Center, Department of clinical Pharmacology, Kragujevac

e-adresa: slobnera@eunet.yu

Sažetak

Članak ne sadrži sažetak.

Ključne reči

Reference

*** (2000) American College of Clinical Pharmacology response to the Institute of Medicine report 'To err is human: Building a safer health system'. The Public Policy Committee. J Clin Pharmacol, 40(10): 1075-8
Bhagat, K., Tisocki, K. (1999) Clinical pharmacologist wanted: Where?. Cent Afr J Med, 45(4): 107-9
Brown, J.M., Helling, D.K., Burns, E.A., Burmeister, L.F., Rakel, R.E. (1982) Patient care telephone calls received in family practice offices. J Fam Pract, 14(3): 527-32
Carmichael, J.M., Alvarez, A., Chaput, R., DiMaggio, J., Magallon, H., Mambourg, S. (2004) Establishment and outcomes of a model primary care pharmacy service system. Am J Health Syst Pharm, 61(5): 472-82
Carter, B.L. (1990) Pharmacotherapy and the primary care physician. Prim Care, 17(3): 469-77
Cooper, J., Benjamin, M. (2004) Clinical audit in practice. Nurs Stand, 18(28): 47-53; qui
Eklof, A., Thurelius, A., Garle, M., Rane, A., Sjoqvist, F. (2003) The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol, 59(8-9): 571-7
Epstein, A.M., Blumenthal, D. (1993) Physician payment reform: Past and future. Milbank Q, 71(2): 193-215
Feely, J. (1993) Drug utilization and clinical pharmacology. Report on British Pharmacological Society Symposium at Trinity College Dublin on Thursday, 9th July, 1992. Br J Clin Pharmacol, 36(5): 483-6
Frolich, J.C. (1997) Positive lists/negative lists from the viewpoint of clinical pharmacology. Z Arztl Fortbild Qualitatssich, 91(7): 627-9
Gold, H. (1952) The proper study of mankind is man. Am J Med, 12: 619
Golden, A.G., Silverman, M.A., Preston, R.A. (1999) University of Miami division of clinical pharmacology therapeutic rounds: Issues in prescribing for geriatric patients and emerging practice guidelines. Am J Ther, 6(6): 341-8
Harder, S., Thurmann, P., Steioff, A. (1998) Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy. Med Klin (Munich), 93(2): 119-24
Heisterberg, J., Christophersen, A.B., Christensen, H.R., Sonne, J. (1999) Clinical pharmacological drug information. Well over one year's experience. Ugeskr Laeger, 161(26): 4005-7
Jankovic, S.M., Maksimovic, M.R., Vusanovic, A., Kostic, I.R., Kovacevic, Z.N., Mitric, M. (2001) Service quality in public and private pharmacies in the City of Kragujevac, FR Yugoslavia
Jankovic, S.M., Milovanovic, D.R., Nedovic, D., Petrovic, S. (2004) Semi-intensive versus intensive monitoring of adverse drug reactions in a hospital
Jankovic, S.M. (2004) The clinical pharmacology departments should develop their services according to the local health care needs
Janković, S.M., Đukić-Dejanović, S.M. (2001) Drug utilization trends in clinical hospital center ?Kragujevac? from 1997 to 1999. Indian Journal of Pharmacology, 33: 29-36
Janković, S.M., Timotijević, I., Mihajlović, G.S., Đukic-Dejanović, S.M. (1999) Comparison of two approaches to amitriptyline dose individualisation. Eur J Drug Metab Pharmacokinet, 24(2): 163-8
Lathers, C.M. (2000) Lessons learned from the past: A guide for the future of clinical pharmacology in the 21st century. J Clin Pharmacol, 40(9): 946-66
Lundborg, C.S., Hensjo, L.O., Gustafsson, L.L. (1997) 'Academic drug-detailing': From project to practice in a Swedish urban area. Eur J Clin Pharmacol, 52(3): 167-72
McClean, H., Evans, A., Yorkshire Multi-District Genitourinary Medicine Clinical Audit Group (2004) A multi-district audit of the management of syphilis in genitourinary medicine clinics in Yorkshire. Int J STD AIDS, 15(3): 183-8
Milovanović, D.R., Pavlović, R., Folić, M., Janković, S.M. (2004) Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country
Ministry of Public Health of the Republic of Serbia (2004) Conditions that have to be fulfilled by a provider of CME. The Decision of the Commission for CME. Belgrade
Nigenda, G. (1994) Physician payment mechanisms. An instrument of health policy. Salud Publica Mex, 36(3): 301-9
Ohman, B., Lyrvall, H., Tornqvist, E., Alvan, G., Sjoqvist, F. (1992) Clinical pharmacology and the provision of drug information. Eur J Clin Pharmacol, 42(6): 563-7
Potthoff, F., Munscher, C. (2004) Elements of managed care in Germany and in Switzerland. MMW Fortschr Med, 146(12): 46-9
Rodriguez-Moreno, C., Campoamor, F., Martin, M.V., Muro, V. (1996) Clinical pharmacology in primary care: A good mix?. Therapie, 51(4): 378-81
Sjoqvist, F. (1999) The past, present and future of clinical pharmacology. Eur J Clin Pharmacol, 55(8): 553-7
Wallack, S.S., Tompkins, C.P. (2003) Realigning incentives in fee-for-service Medicare. Health Aff (Millwood), 22(4): 59-70
Walther, H., Meyer, F.P., Quednow, B., Leuschner, U., Kohler, E., Horenburg, I. (1978) Dosage monitoring through measurement of serum level: A task of clinical pharmacology. Int J Clin Pharmacol Biopharm, 16(8): 387-90
Walton, C.A., Knodel, L.C. (1983) Drug information centers: ASHP's role and effect of clinical pharmacy. Am J Hosp Pharm, 40(7): 1217-8
Wettermark, B., Pehrsson, A., Jinnerot, D., Bergman, U. (2003) Drug utilisation 90% profiles: A useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf, 12(6): 499-510
Wilson, J.T., Brown, R.D., Kimura, K.K., Whelton, A. (1989) Profile of clinical pharmacologists in the United States. J Clin Pharmacol, 29(8): 695-713
World Health Organization (2000) Operational guidelines for ethics committees that review biomedical research. Geneva: WHO